Rethinking the Pharma-Diagnostic Partnership: How Specialist Oversight Can Reduce Complexity, Manage Risk & Optimize the Clinical Trial Lifecycle

• Simplify complex IVD study responsibilities with clearer ownership and accountability across the clinical trial lifecycle
• Reduce handovers, gaps and duplication across diagnostic partners, vendors and workstreams
• Strengthen oversight and coordination across multiple diagnostic partners and activities
• Reduce risk, save time and ease pressure on internal teams through a more integrated approach

Speakers: